Profound Medical Corp (PRN.TO)
10.61
+0.06
(+0.57%)
CAD |
TSX |
Nov 22, 16:00
Profound Medical Total Liabilities (Quarterly): 15.09M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 15.09M |
| June 30, 2024 | 14.78M |
| March 31, 2024 | 15.60M |
| December 31, 2023 | 16.88M |
| September 30, 2023 | 16.15M |
| June 30, 2023 | 16.48M |
| March 31, 2023 | 16.91M |
| December 31, 2022 | 16.84M |
| September 30, 2022 | 5.422M |
| June 30, 2022 | 6.627M |
| March 31, 2022 | 7.252M |
| December 31, 2021 | 7.847M |
| September 30, 2021 | 7.080M |
| June 30, 2021 | 7.388M |
| March 31, 2021 | 7.998M |
| December 31, 2020 | 9.246M |
| September 30, 2020 | 7.280M |
| June 30, 2020 | 7.304M |
| March 31, 2020 | 7.482M |
| December 31, 2019 | 20.49M |
| Date | Value |
|---|---|
| September 30, 2019 | 19.61M |
| June 30, 2019 | 19.39M |
| March 31, 2019 | 20.98M |
| December 31, 2018 | 19.93M |
| September 30, 2018 | 18.48M |
| June 30, 2018 | 10.14M |
| March 31, 2018 | 10.24M |
| December 31, 2017 | 13.73M |
| September 30, 2017 | 13.06M |
| June 30, 2017 | 9.312M |
| March 31, 2017 | 9.932M |
| December 31, 2016 | 8.881M |
| September 30, 2016 | 9.135M |
| June 30, 2016 | 7.930M |
| March 31, 2016 | 7.722M |
| December 31, 2015 | 7.223M |
| September 30, 2015 | 7.576M |
| June 30, 2015 | 7.671M |
| March 31, 2015 | 0.1254M |
| September 30, 2014 | 0.0392M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.422M
Minimum
Sep 2022
20.49M
Maximum
Dec 2019
11.51M
Average
8.622M
Median
Total Liabilities (Quarterly) Benchmarks
| Biocure Technology Inc | 0.44M |
| Core One Labs Inc | 1.759M |
| Restart Life Sciences Corp | 1.072M |
| Nanosphere Health Sciences Inc | 2.276M |
| Lobe Sciences Ltd | 3.073M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 57.05M |
| Shareholders Equity (Quarterly) | 41.96M |
| Debt to Equity Ratio | 0.1802 |
| Current Ratio | 6.123 |
| Net Debt Paydown Yield | 0.16% |